Self-Limited Viral Hepatitis: A, E, CMV, EBV

  • Enrique J. Martinez
  • Lennox Jeffers
Part of the Current Clinical Practice book series (CCP)


The term self-limited viral hepatitis refers to diseases caused by a special group of viruses that have a tendency to attack liver. Although they have the potential to cause significant morbidity and mortality in the acute phase of their illness, they never cause chronic hepatitis. Infections tend to be more severe in immunocompromised individuals.


Hepatic Encephalopathy Biliary Atresia Fulminant Hepatitis Infectious Mononucleosis Hepatocellular Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hilleman MR. Hepatitis an hepatitis A vaccine: a glimpse of history. J Hepatol 1993; 18:S5–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995; 171:S19–23.PubMedCrossRefGoogle Scholar
  3. 3.
    Mishra L, Seef LB. Viral hepatitis, A through E, complicating pregnancy. Gastro Clin North Am 1992;21:873–887.Google Scholar
  4. 4.
    Centers for Disease Control. Hepatitis surveillance report. 1990;53:23.Google Scholar
  5. 5.
    Center for Disease Control and Prevention. Summary of notifiable diseases. MMWR 1993;41:3.Google Scholar
  6. 6.
    Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis 1995;171:S2–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Fagan E, Yousef G, Brahm J, Garelick H, Mann G, Wolstenholme A, Portmann B, Harrison T, Mowbray JF, Mowat A, et el. Persistence of hepatitis A virus before and after liver transplantation for fulminant hepatitis. J. Med Virol 1990;30:131–136.PubMedCrossRefGoogle Scholar
  8. 8.
    Halliday ML, Kang LY, Zhou TK. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shangai, China. J Infect Dis 1991;164:852–859.Google Scholar
  9. 9.
    Reves RR, Pickering LK. Impact of child day care on infectious diseases in adults. Inf Dis Clinic North Am 1992;6:239–250.Google Scholar
  10. 10.
    Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastro Clin North Am 1994;23:437–455.Google Scholar
  11. 11.
    Watson JC, Fleming DW, Borella AJ, Olcott ES, Conrad RE, Baron RC. Vertical transmission of hepatitis A in a neonatal intensive care unit. J Infect Dis 1993; 167:567–571.PubMedCrossRefGoogle Scholar
  12. 12.
    Center for Disease Control and Prevention. Summary of notifiable diseases. United States. 1992. MMWR 1993;41:32.Google Scholar
  13. 13.
    Minuk GY, Ding LX, Hannon C, Sekla L. The risks of household transmission of acute hepatitis A and B virus infection in an urban centre [abstract]. Hepatology 1993; 18:76a.Google Scholar
  14. 14.
    Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10:S59–62.PubMedCrossRefGoogle Scholar
  15. 15.
    McNair ANB, Main J, Thomas HC. Interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 1992;12:188–196.PubMedCrossRefGoogle Scholar
  16. 16.
    Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992;10:S15–17.PubMedCrossRefGoogle Scholar
  17. 17.
    Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985; 122:226–233.PubMedGoogle Scholar
  18. 18.
    Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992;10:S18–20.PubMedCrossRefGoogle Scholar
  19. 19.
    Phillips AO, Thomas DM, Coles GA. Acute renal failure associated with non-fulminant hepatitis A. Clin Nephrol 1993;39:156,157.PubMedGoogle Scholar
  20. 20.
    Geltner D, Naot Y, Zimhoni O, Garbach S, Bar-Khayim Y. J Clin Acute oliguric renal failure complicating type A nonfulminant viral hepatitis. Gastroenterology 1992; 14:160–162.Google Scholar
  21. 21.
    Huppertz HI, Treichel V, Gassel AM, Jeschke R, Meyer zum Buschenfelde KH. Autoimmune hepatitis following hepatitis A virus infection. J Hepatology 1995;23:204–208.CrossRefGoogle Scholar
  22. 22.
    Ramahan SM, Chira P, Koff RS. Idiopathic autoimmune hepatitis triggered by hepatitis A. Am J Gastro 1994;89:106–108.Google Scholar
  23. 23.
    Tong MJ, El-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Inf Dis 1995;171:S15–18.CrossRefGoogle Scholar
  24. 24.
    Karayiannis P, Chitranukroh R, Fry M, Petrovic LM, Moore D, Scheuer PJ, Thomas HC. Protracted alanine aminotransferase levels in tamarins infected with hepatitis A virus. J. Med Virol 1990;30:151–158.PubMedCrossRefGoogle Scholar
  25. 25.
    Brunt PW. Alcohol and chronic liver disease. J. Roy Coll Phys Lond. 1974;8:45–51.Google Scholar
  26. 26.
    Anonymous, How long should patients keep off alcohol after infectious hepatitis? Drug Ther Bull 1975;13:87, 88.Google Scholar
  27. 27.
    Krieg D, Weigl E, Bach H. Prognosis of chronic hepatitis. Acta Hepatogastroenterol 1976;23:168–172.Google Scholar
  28. 28.
    McNeil M, Hoy JF, Richards MJ. Aetiology of fatal viral hepatitis in Melbourne: a retrospective study. Med J Aust 1984; 141:637–640.PubMedGoogle Scholar
  29. 29.
    Papaevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richarson C. Etiology of fulminant hepatitis in Greece. Hepatology 1984;4:369–372.PubMedCrossRefGoogle Scholar
  30. 30.
    O’Grady J. Management of acute and fulminant hepatitis. Vaccine 1992;10:S21–23.PubMedCrossRefGoogle Scholar
  31. 31.
    Zuckerman AJ. Viral hepatitis. Transfus Med 1993;3:7–19.PubMedCrossRefGoogle Scholar
  32. 32.
    Keefe EB. Is hepatitis A more severe in patients with chronic hepatitis B than other chronic liver diseases? Am J Gastroenterol 1995;90:201–205.Google Scholar
  33. 33.
    Agarwal R, Naik SR. Hepatitis E: intrafamilial versus waterborne spread. J Hepatol 1994;21:718–723.CrossRefGoogle Scholar
  34. 34.
    Wald A. Hepatitis E. Adv Pediatr Infect Dis 1995;10:157–166.PubMedGoogle Scholar
  35. 35.
    Bradley DW. Enterically transmitted non-A, non-B hepatitis. Br Med Bull 1990;46:442–461.PubMedGoogle Scholar
  36. 36.
    Velasquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, Hadler SC, Bradley DW, Sepulveda J. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986–1987. JAMA 1990;263:3281–3285.CrossRefGoogle Scholar
  37. 37.
    Kane, MA, Bradley DW, Shrestha SM, Maynard JE, Cook EH, Mishra RP, Joshi DD. Epidemic non-A, non-B hepatitis in Nepal; recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984;252;3140–3145.PubMedCrossRefGoogle Scholar
  38. 38.
    Khuroo MS, Dar MY, Hepatitis E: evidence for person-to-person transmission and inability of a low dose immune serum globulin from an Indian source to stop it. Indian J. Gastroenterol 1992;11:113–116.PubMedGoogle Scholar
  39. 39.
    Mahon JB, Chernesky MA. Vertical transmission of viral hepatitis. Transfus Med Rev 1993;7:112–120.CrossRefGoogle Scholar
  40. 40.
    Robson SC, Adams S, Brink N, et al. Hospital outbreak of hepatitis E. Lancet 1992;339:1424,1425.PubMedCrossRefGoogle Scholar
  41. 41.
    Nanda SK, Ansari IH, Acharya SK. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 1995;108:225–230.PubMedCrossRefGoogle Scholar
  42. 42.
    Chauhan A, Jameel S, Dilwari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet 1993;341:149,150.PubMedCrossRefGoogle Scholar
  43. 43.
    Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252–255.PubMedCrossRefGoogle Scholar
  44. 44.
    Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E Virus. Lancet 1995;345:1025,1026.PubMedCrossRefGoogle Scholar
  45. 45.
    Arankalle VA, Jha J, Favoroc MO, Chaudhari A, Fields HA, Banerjee K. Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India. J Viral Hep 1995;2:189–193.CrossRefGoogle Scholar
  46. 46.
    Bryan JP, Tsarev SA, Iqbal M, Ticehurst J, Emerson S, Ahmed A, Duncan J, Rafiqui AR, Malik IA, Purcell RH; et al. Epidemic hepatitis E in Pakistan patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J. Infect Dis 1994; 170:517–521.PubMedCrossRefGoogle Scholar
  47. 47.
    Griffiths PD. Cytomegalovirus and the liver. Sem Liver Dis 1984;4:307–313.CrossRefGoogle Scholar
  48. 48.
    Alford CA. An epidemiological review of intrauterine and perinatal infections of man. Mead Johnson Symp Perinat Dev Med 198;21:3-11.Google Scholar
  49. 49.
    Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA Jr. Maternal cytomegalovirus excretion and perinatal infection. N Eng J Med 1973;289:1–5.CrossRefGoogle Scholar
  50. 50.
    Satgnos S, Reynolds DW, Pass RF, Alford CA. Breast milk and the risk of cytomegalovirus infection. N Eng J Med 1980;302:1073–1076.CrossRefGoogle Scholar
  51. 51.
    Weiler TH. The cytomegaloviruses, ubiquitous agents with protean clinical manifestations. N End J Med 1971;285:203–224.CrossRefGoogle Scholar
  52. 52.
    Hanshaw JB. Cytomegalovirus In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 2nd ed. Saunders, Philadelphia, 1983.Google Scholar
  53. 53.
    Danks DM, Campbell PE, Jack I. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child 1977;52:360–367.PubMedCrossRefGoogle Scholar
  54. 54.
    Dresler S, Linder D. Noncirrhotic portal fibrosis following neonatal cytomegalic inclusion disease. J. Pediatr 1978;93:887,888.PubMedCrossRefGoogle Scholar
  55. 55.
    Hanshaw JB, Betts RF, Simon G, Boynton RC. Acquired cytomegalovirus infection: association with hepatosplenomegaly and abnormal liver-function tests. N Engl J Med 1965;272:602–609.PubMedCrossRefGoogle Scholar
  56. 56.
    Oppenheimer EH, Esterly JR. Cytomegalovirus infection: a possible cause of biliary atresia. Am J Pathol 1973;71:2a.Google Scholar
  57. 57.
    Felber S, Sinatra F. Systemic disorders associated with neonatal cholestasis. Sem Liver Dis 1987;7: 108–118.CrossRefGoogle Scholar
  58. 58.
    Finegold MJ, Carpenter RJ. Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum Pathol 1982; 13:662–665.PubMedCrossRefGoogle Scholar
  59. 59.
    Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH Jr. Ganciclovir treatment of cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum Pathol 1982; 13:662–665.CrossRefGoogle Scholar
  60. 60.
    Shaefer MS, Stratta RJ, Markin RS, Cushing KA, Woods GL, Reed EC, Wood RP, Langras AN, Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients. Transpl Proc 191;23:1515,1516.Google Scholar
  61. 61.
    Shusterman NH, Frauenhoffer C, Kinsey MD. Fatal Massive hepatic necrosis in cytomegalovirus mononucleosis. Ann Intern Med 1978;88:810–812.PubMedGoogle Scholar
  62. 62.
    Tucciarone L, Felici W, Nigro G. Un caso di malattia citomegalica acquisita a decorso fatale. Riv Ital Pediatr 1989;15:643–646.Google Scholar
  63. 63.
    Henle W, Henle G. Epstein-Barr virus and infectious mononucleosis. N Engl J Med 1973;288:263–264.PubMedCrossRefGoogle Scholar
  64. 64.
    Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY. Leukocyte transforming agent: prolonged excretion by patients with mononucleosis and excretion b normal individuals. J Infect Dis 1973:127;471–473.PubMedCrossRefGoogle Scholar
  65. 65.
    Niederman JC, Miller G, Pearson HA, Pagano JS, Dowaliby JM. Infectious mononucleosis. Epstein-Barr virus shedding in saliva and oropharynx. N Engl J Med 1976;294:1355–1359.PubMedCrossRefGoogle Scholar
  66. 66.
    Corey L, Stamm WE, Feorino PM, Bryan JA, Weseley S, Gregg MB, Solangi K. HBS Ag negativve hepatitis in a haemodialysis unit: relation to Epstein-Barr virus. N Engl J Med 1975; 293:1273–1278.PubMedCrossRefGoogle Scholar
  67. 67.
    Madigan NP, Newcomer AD, Campbell DC, Taswell HF. Intense jaundice in infectious mononucleosis. Mayo Clin Proc 1973;48:857–862.PubMedGoogle Scholar
  68. 68.
    Durbin WA, Sullivan JL. Epstein-Barr virus infection. Ped Rev 1994;15:63–68.CrossRefGoogle Scholar
  69. 69.
    White NJ, Juel-Jensen BE. Infectious mononucleosis hepatitis. Sem Liver Dis 1984;4:301–306.CrossRefGoogle Scholar
  70. 70.
    Brady M. Epstein-Barr virus infection in children: implications for the treatment of infectious mononucleosis. J Pediatr Health Care 1994;8:233–235.PubMedCrossRefGoogle Scholar
  71. 71.
    Horowitz CA, Henle W, Henle G. Infectious mononucleosis in older patients age 4-72 years. Report of 27 cases including three without heterophile antibody response. Medicine 1983;62:256–262.CrossRefGoogle Scholar
  72. 72.
    Ansari A, Grotte M. Acute hepatitis as a primary manifestation of infectious mononucleosis in a 53 year old man. Am J Gastroenterol 1984;79:471–473.PubMedGoogle Scholar
  73. 73.
    Jacobson IM, Gang DL, Shapiro RH. Epstein-Barr viral hepatitis: an unusual case and review of the literature. Am J Gastroenterol 1984;79:628–632.PubMedGoogle Scholar
  74. 74.
    Hoagland RJ. Infectious mononucleosis. Grune and Stratton, New York 1967.Google Scholar
  75. 75.
    Kilpatrick ZM. Structural and functional abnormalities of liver in infectious mononucleosis. Arch Intern Med 1966;117:47–53.PubMedCrossRefGoogle Scholar
  76. 76.
    Nelson RS, Darragh JH. Infectious mononucleosis hepatitis. Am J Med 1950;21:26–33.CrossRefGoogle Scholar
  77. 77.
    Powell MA. Question and Answer. Infectious mononucleosis. J Am Acad Nurse Pract 1993;5:89–91.PubMedCrossRefGoogle Scholar
  78. 78.
    Wadsworth RC, Keil PG. Biopsy of the liver in infectious mononucleosis. Am Fam Phys 1994;49:879–885.Google Scholar
  79. 79.
    Bailer ER, Diagnosis and treatment of infectious mononucleosis. Am Fam Phys 1994;49:879–885.Google Scholar
  80. 80.
    Andersson J, Ernberg I. Management of Epstein-Barr virus infections. Am J Med 1988;85:107–115.PubMedCrossRefGoogle Scholar
  81. 81.
    Andersson J, Britton S, Ernberg I, Andersson U, Henle W, Skoldenberg B, Tisell A. Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. J Infect Dis 1986; 153:283–290.PubMedCrossRefGoogle Scholar
  82. 82.
    Andersson J, Skoldenberg B, Henle W. Acyclovir treatment in infectious mononucleosis: a clinical and virological study. Infection 1987;15:S14–20.PubMedCrossRefGoogle Scholar
  83. 83.
    Van der horst C, Joncas J, Ahronheim G, Gustafson N, Stein G, Gurwith M, Fleisher G, Sullivan J, Sixbey J, Roland S, et al. Lack of affect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991;164:788–792.PubMedCrossRefGoogle Scholar
  84. 84.
    Lowe L, Hebert AA, Duvie M. Gianotti-Cristi syndrome associated with Epstein-Barr virus infection. J Am Acad Dermatol 1989;29:336–338.CrossRefGoogle Scholar
  85. 85.
    Costa S, Barrasso R, Terzano P, Zerbini M, Carpi C, Musiani M, et al. Detection of active Epstein-Barr virus infection in pregnant women. Eur J Clin Microbiol 1985;4:335, 336.PubMedCrossRefGoogle Scholar
  86. 86.
    Goldberg GN, Fulginiti VA, Ray CG, Ferry P, Jones JF, Cross H, Minnich L. In utero Epstein-Barr virus (infectious mononucleosis) infection. JAMA 1981;246:1579–1581.PubMedCrossRefGoogle Scholar
  87. 87.
    Joncas JH, Alfieri C, Leyritz-Wills M, Brochu P, Jasmin G, Boldogh I, Huang ES. Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. N Engl J Med 1981;304:1399–1403.PubMedCrossRefGoogle Scholar
  88. 88.
    Robinson RG. Abdominal complications of infectious mononucleosis. J Am Board Fam Pract 1988; 1:207–210.PubMedGoogle Scholar
  89. 89.
    Sakamoto T, Uemure M, Fukui H, Yoshikawa M, Fukui K, Kinoshita K, Kojima H, Matsumori T, Tsujii T, Sumazaki R. Chronic active Epstein-Barr hepatitis in an adult. Intern Med 1992;31:1190–1196.PubMedCrossRefGoogle Scholar
  90. 90.
    Haines JD Jr. When to resume sports after infectious mononucleosis. How soon is safe? Postgrad Med 1987;81:331–333.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Enrique J. Martinez
  • Lennox Jeffers

There are no affiliations available

Personalised recommendations